End-of-day quote
Other stock markets
|
||
- USD | - |
06-17 | MyMD Pharmaceuticals, Inc. announced that it has received $14 million in funding from PharmaCyte Biotech, Inc. | CI |
05-23 | MyMD Pharmaceuticals, Inc. amended terms of the transaction | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Joshua Silverman
CEO | Chief Executive Officer | 54 | 22-08-14 |
Carlos Trujillo
DFI | Director of Finance/CFO | 66 | 14-12-31 |
José Iglesias
CTO | Chief Tech/Sci/R&D Officer | - | 20-08-09 |
Lilli Brandtner
PRN | Corporate Officer/Principal | - | 15-02-09 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Weinstein
BRD | Director/Board Member | 64 | 22-11-13 |
Joshua Silverman
CEO | Chief Executive Officer | 54 | 22-08-14 |
Wayne Walker
BRD | Director/Board Member | 65 | 22-12-27 |
Carlos Trujillo
DFI | Director of Finance/CFO | 66 | 14-12-31 |
Director/Board Member | 50 | 22-08-14 | |
Director/Board Member | 65 | 17-07-09 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 21,604,315 | 7,767,289 ( 35.95 %) | 13,150,919 ( 60.87 %) | 35.95 % |
Stock B | 0 | 35,000 | 0 | 0 |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
FEMASYS INC. -.--% | 0 | -.--% | 0 $ |
0 | -.--% | 0 $ |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+56.89% | 823B | |
+39.52% | 627B | |
-6.55% | 353B | |
+15.99% | 320B | |
+7.92% | 295B | |
+13.74% | 239B | |
+13.83% | 220B | |
-0.49% | 219B | |
+7.94% | 167B |
- Stock Market
- Equities
- PMCB Stock
- Stock
- Company Pharmacyte Biotech Inc